News
3h
Zacks Investment Research on MSNAmgen vs Bristol Myers: Which Biotech Giant Has Better Prospects?Amgen AMGN and Bristol Myers Squibb BMY are among the largest global biotechnology companies with broad and diverse ...
Among the safety stocks discussed by Cramer during the episode on May 14, Bristol-Myers Squibb Company (NYSE:BMY) was first ...
Bristol-Myers Squibb Co. prevailed against investor allegations it misled them about a payout tied to Food and Drug ...
Shares of Bristol Myers Squibb Co. rose 3.83% to $45.81 Thursday, on what proved to be an all-around great trading session ...
Bristol Meyers Squibb has been employing New Jersey residents for well over a century. After decades of expanding, there have ...
Although the Trump administration's healthcare policies pose risks for Bristol-Myers Squibb, the chaos opens a contrarian door for BMY stock.
Shares of Bristol Myers Squibb Co. BMY slipped 1.55% to $46.88 Thursday, on what proved to be an all-around positive trading ...
My shift schedule allowed me to allocate time to complete my third-level education - a biopharmaceutical processing degree at ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Recently, the Trump Administration signed an executive order to lower the prices Americans pay for prescription drugs. It's no secret that brand-name drugs in the U.S. are much more expensive than ...
In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results